Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus lidocaine-prilocaine cream for perioperative invasive puncture pain
ChiCTR2300069970Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Apr 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and lidocaine + prilocaine in perioperative pain and anxiety disorder (3 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoints: NRS pain score during puncture and Anxiety score. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
remimazolamlidocaine + prilocaine
03
Conditions
perioperative painanxiety disorder
Beyond the preview
Go deeper on ChiCTR2300069970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069970.